参考文献
［1］Flynn J A L, Chan J. Immunology of tuberculosis ［J］. Annual review of immunology, 2001, 19（1）: 93-129.
［2］Morris K R, Lutz R D, Choi H S, et al. Role of the NF-κB signaling pathway and κB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide［J］. Infection and immunity, 2003, 71（3）: 1442-1452.
［3］宋艳华, 高孟秋. 肿瘤坏死因子-α 在抗结核免疫中的作用研究进展［J］.中国防痨杂志, 2012, 34（04）: 254-258.
［4］Küpeli E, Karnak D, Beder S, et al. Diagnostic accuracy of cytokine levels（TNF-alpha, IL-2 and IFN-gamma） in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients. Respiration. 2008;75（1）:73-78. doi:10.1159/000110744
［5］杨颖乔, 彭圣威. 肺结核患者细胞因子水平测定的临床研究［J］. 咸宁学院学报: 医学版, 2009, 23（3）: 211-212.
［6］Nolan A, Fajardo E, Huie M L, et al. Increased production of IL-4 and IL-12p40 from bronchoalveolar lavage cells are biomarkers of Mycobacterium tuberculosis in the sputum［J］. PLoS One, 2013, 8（3）: e59461.
［7］Price N M, Gilman R H, Uddin J, et al. Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-αdependent monocyte networks ［J］. The Journal of Immunology, 2003, 171（10）: 5579-5586.
［8］Novak T E, Babcock T A, Jho D H, et al. NF-κB inhibition by ω-3 fatty acids modulates LPS -stimulated macrophage TNF -α transcription［J］.American Journal of Physiology-Lung Cellular and Molecular Physiology,2003, 284（1）: L84-L89.
［9］Ndlovu H, Marakalala M J. Granulomas and inflammation: host-directed therapies for tuberculosis［J］. Frontiers in immunology, 2016, 7: 434.
［10］Stallings C L. Host response: Inflammation promotes TB growth［J］. Nature microbiology, 2017, 2（7）: 1-2.
［11］Cadena A M, Flynn J A L, Fortune S M. The importance of first impressions:early events in Mycobacterium tuberculosis infection influence outcome［J］.MBio, 2016, 7（2）.
［12］Algood H M S, Chan J, Flynn J A L. Chemokines and tuberculosis［J］.Cytokine & growth factor reviews, 2003, 14（6）: 467-477.
［13］Ehlers S. DC-SIGN and mannosylated surface structures of Mycobacterium tuberculosis: a deceptive liaison［J］. European journal of cell biology, 2010,89（1）: 95-101.
［14］Hwang S A, Actor J K. Modulation of inflammation to control tuberculosis disease［M］//Translational Inflammation. Academic Press, 2019: 133-152.
［15］Liu C H, Liu H, Ge B. Innate immunity in tuberculosis: host defense vs pathogen evasion［J］.Cellular&molecular immunology,2017,14（12）:963-975.
［16］Lee C H, Kim H J, Lee Y S, et al. Hypothalamic macrophage inducible nitric oxide synthase mediates obesity-associated hypothalamic inflammation［J］.Cell reports, 2018, 25（4）: 934-946. e5.
［17］Mishra B B, Lovewell R R, Olive A J, et al. Nitric oxide prevents a pathogenpermissive granulocytic inflammation during tuberculosis ［J］. Nature microbiology, 2017, 2（7）: 1-11.
［18］Gengenbacher M, Duque-Correa M A, Kaiser P, et al. NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans［J］. Scientific reports, 2017, 7（1）: 1-10.
［19］Chan E D, Bai X, Musheyev A, et al. Mycobacterial Species Differ in Intracellular Survival, Cytokine mRNA Expression, NF-Kappa B Activation,and Macrophage Apoptosis［M］//B105. MYCOBACTERIAL HOST DEFENSE AND PATHOGENESIS. American Thoracic Society, 2018: A4309-A4309.
［20］Amelio P, Portevin D, Reither K, et al. Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell responses in patients with active pulmonary tuberculosis from Tanzania［J］. PLoS neglected tropical diseases, 2017, 11（7）:e0005817.
［21］Wang F, Hou H, Xu L, et al. Mycobacterium tuberculosis-specific TNF-α is a potential biomarker for the rapid diagnosis of active tuberculosis disease in Chinese population［J］. PLoS One, 2013, 8（11）: e79431.
［22］Keane J, Gershon S, Wise R P, et al. Tuberculosis associated with infliximab,a tumor necrosis factor α–neutralizing agent［J］. New England Journal of Medicine, 2001, 345（15）: 1098-1104.
［23］Tzelepis F, Blagih J, Khan N, et al. Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to tuberculosis［J］. Science immunology, 2018, 3（23）.
［24］Tezera L B, Bielecka M K, Ogongo P, et al. Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α［J］.Elife,2020,9:e52668.
［25］Kishimoto T. IL-6: from its discovery to clinical applications［J］. International immunology, 2010, 22（5）: 347-352.
［26］Huang W L, Yeh H H, Lin C C, et al. Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells［J］. Molecular cancer, 2010, 9（1）: 1-16.
［27］Borges A H, O'Connor J L, Phillips A N, et al. Determinants of IL-6 levels during HIV infection［J］. Journal of the international AIDS society, 2014, 17.
［28］Ogawa T, Uchida H, Kusumoto Y, et al. Increase in tumor necrosis factor alpha-and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis ［J］. Infection and immunity, 1991, 59（9）: 3021-3025.
［29］Jung B G, Wang X, Yi N, et al. Early secreted antigenic target of 6-kDa of Mycobacterium tuberculosis stimulates IL -6 production by macrophages through activation of STAT3［J］. Scientific reports, 2017, 7（1）: 1-14.
［30］Nagabhushanam V, Solache A, Ting L M, et al. Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-γ［J］.The Journal of Immunology,2003,171（9）:4750-4757.
［31］Dutta R K, Kathania M, Raje M, et al. IL-6 inhibits IFN-γ induced autophagy in Mycobacterium tuberculosis H37Rv infected macrophages ［J］. The international journal of biochemistry&cell biology,2012,44（6）:942-954.
［32］Paré A, Mailhot B, Lévesque S A, et al. IL-1β enables CNS access to CCR2hi monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells ［J］. Proceedings of the National Academy of Sciences, 2018, 115（6）: E1194-E1203.
［33］Pan M H, Maresz K, Lee P S, et al. Inhibition of TNF-α, IL-1α, and IL-1β by pretreatment of human monocyte-derived macrophages with menaquinone-7 and cell activation with TLR agonists in vitro［J］. Journal of medicinal food,2016, 19（7）: 663-669.
［34］Hackett E E, Charles-Messance H, O’Leary S M, et al. Mycobacterium tuberculosis Limits Host Glycolysis and IL-1β by Restriction of PFK-M via MicroRNA-21［J］. Cell Reports, 2020, 30（1）: 124-136. e4.
［35］Gopalakrishnan A, Salgame P. Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be—that is the question［J］.Current opinion in immunology, 2016, 42: 76-82.
［36］Cervantes J L. MyD88 in Mycobacterium tuberculosis infection［J］. Medical Microbiology and Immunology, 2017, 206（3）: 187-193.
［37］Liu T, Zhang L, Joo D, et al. NF-κB signaling in inflammation［J］. Signal transduction and targeted therapy, 2017, 2（1）: 1-9.
［38］Carlos D, Frantz F G, Souza-Júnior D A, et al. TLR2-dependent mast cell activation contributes to the control of Mycobacterium tuberculosis infection［J］. Microbes and infection, 2009, 11（8-9）: 770-778.
［39］Russell D G, Cardona P J, Kim M J, et al. Foamy macrophages and the progression of the human tuberculosis granuloma ［J］. Nature immunology,2009, 10（9）: 943-948.
［40］Gern B H, Adams K N, Plumlee C R, et al. TGFβ restricts T cell function and bacterial control within the tuberculous granuloma ［J］. CELL -HOST -MICROBE-D-20-00093, 2019.
［41］Noss E H, Pai R K, Sellati T J, et al. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19 -kDa lipoprotein of Mycobacterium tuberculosis ［J］. The Journal of immunology, 2001, 167（2）: 910-918.
［42］Arko‐Mensah J, Julian E, Singh M, et al. TLR2 but not TLR4 Signalling is Critically Involved in the Inhibition of IFN ‐ γ ‐ induced Killing of Mycobacteria by Murine Macrophages ［J］. Scandinavian journal of immunology, 2007, 65（2）: 148-157.
［43］Lugo-Villarino G, Vérollet C, Maridonneau-Parini I, et al. Macrophage polarization: convergence point targeted by mycobacterium tuberculosis and HIV［J］. Frontiers in immunology, 2011, 2: 43.
［44］Qin Y, Sun X, Shao X, et al. Macrophage-microglia networks drive M1 microglia polarization after mycobacterium infection［J］. Inflammation, 2015,38（4）: 1609-1616.
［45］Jo E K, Silwal P, Yuk J M. AMPK-targeted effector networks in mycobacterial infection［J］. Frontiers in microbiology, 2019, 10: 520.
［46］Deng J, Miller S A, Wang H Y, et al. β-catenin interacts with and inhibits NFκB in human colon and breast cancer［J］.Cancer cell,2002,2（4）:323-334.
［47］Liu J, Liao Y, Ma K, et al. PI3K is required for the physical interaction and functional inhibition of NF-κB by β-catenin in colorectal cancer cells［J］.Biochemical and Biophysical Research Communications,2013,434（4）:760-766.
［48］Ma B, Hottiger M O. Crosstalk between Wnt/β-catenin and NF-κB signaling pathway during inflammation［J］. Frontiers in immunology, 2016, 7: 378.
［49］Hassa P O, Buerki C, Lombardi C, et al. Transcriptional coactivation of nuclear factor-κB-dependent gene expression by p300 is regulated by poly（ADP）-ribose polymerase-1［J］. Journal of Biological Chemistry, 2003, 278（46）: 45145-45153.
［50］Paul D, Islam S, Manne R K, et al. F‐box protein FBXO16 functions as a tumor suppressor by attenuating nuclear β‐catenin function［J］. The Journal of pathology, 2019, 248（3）: 266-279.
［51］Li R, Wang J, Wang X, et al. Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-κB signaling pathway［J］. Gene, 2016, 592（1）: 164-171.
［52］Phelps R A, Broadbent T J, Stafforini D M, et al. New perspectives on APC control of cell fate and proliferation in colorectal cancer［J］. Cell cycle, 2009,8（16）: 2549-2556.
［53］Schaale K, Neumann J, Schneider D, et al. Wnt signaling in macrophages:augmenting and inhibiting mycobacteria-induced inflammatory responses［J］.European journal of cell biology, 2011, 90（6-7）: 553-559.
［54］Zimmerman Z F, Kulikauskas R M, Bomsztyk K, et al. Activation of Wnt/βcatenin signaling increases apoptosis in melanoma cells treated with trail［J］.PloS one, 2013, 8（7）: e69593.
［55］De la Barrera S, Alemán M, Musella R, et al. IL‐10 down‐regulates costimulatory molecules on Mycobacterium tuberculosis‐pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients［J］. Clinical & Experimental Immunology, 2004, 138（1）: 128-138.
［56］Wu B, Huang C, Kato-Maeda M, et al. Messenger RNA expression of IL-8,FOXP3, and IL-12β differentiates latent tuberculosis infection from disease［J］. The Journal of Immunology, 2007, 178（6）: 3688-3694.
［57］Kornfeld H, Mancino G, Colizzi V. The role of macrophage cell death in tuberculosis［J］. Cell Death & Differentiation, 1999, 6（1）: 71-78.
［58］Demangel C, Bean A G D, Martin E, et al. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin -infected dendritic cells ［J］. European journal of immunology, 1999, 29（6）: 1972-1979.
［59］Kaattari S L, Klemer J V, Evans D A. Teleost antibody structure: simple prototype or elegant alternative ［J］. Bulletin of the European Association of Fish Pathologists, 1999, 19（6）: 245-249.